Moderna, Inc.MRNANASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank22
Year-over-Year Change
Operating cash flow minus capital expenditures
Percentile
P22
Within normal range
vs 5Y Ago
-1.1x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-2.06B | +49.1% |
| 2024 | $-4.05B | -6.0% |
| 2023 | $-3.83B | -183.5% |
| 2022 | $4.58B | -65.6% |
| 2021 | $13.34B | +580.6% |
| 2020 | $1.96B | +499.5% |
| 2019 | $-490.52M | -12.3% |
| 2018 | $-436.63M | -12.0% |
| 2017 | $-389.88M | -1260.7% |
| 2016 | $33.59M | - |